A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma

Single-agent ibrutinib is active in patients with previously treated mantle cell lymphoma (MCL); however, nearly half of all patients experience treatment failure during the first year. We previously demonstrated that prolonged early G1 cell cycle arrest induced by the oral, specific CDK4/6 inhibito...

全面介紹

Na minha lista:
書目詳細資料
發表在:Blood
Main Authors: Martin, Peter, Bartlett, Nancy L., Blum, Kristie A., Park, Steven, Maddocks, Kami, Ruan, Jia, Ridling, LeAnn, Dittus, Christopher, Chen, Zhengming, Huang, Xiangao, Inghirami, Giorgio, DiLiberto, Maurizio, Chen-Kiang, Selina, Leonard, John P.
格式: Artigo
語言:Inglês
出版: American Society of Hematology 2019
主題:
Clinical Trials and Observations
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6418474/
https://ncbi.nlm.nih.gov/pubmed/30692121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-11-886457
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍